Breathing New Life into Parkinson's: Dr. Donald Rhodes on VECTTOR Therapy
The vector unit will test for circulation each time you run it and we'll tell you if you need a new protocol. There are actually hundreds and hundreds of different options that might actually help a particular individual. And so, yeah, we can have a hundred different patients with Parkinson's disease and exactly the same other problems, the comorbidities, the back pain, shoulder pain, dry eyes, wet eyes, trouble sleeping, digestive problems.
Imagine if the key to easing Parkinson's symptoms was as simple as giving your cells a breath of fresh air. That's what Dr. Donald Rhodes MD, inventor of VECTTOR treatments, believes. In this engaging episode of 'Pathways to Parkinson's Relief', Dr. Rhodes shares insights from his extensive experience in electrostimulation therapy.
Recorded over a week at his Houston clinic, this episode offers a deep dive into how VECTTOR treatments work to boost oxygen levels in cells, potentially reversing some symptoms of Parkinson's disease. Dr. Rhodes explains that VECTTOR treatments are painless and non-invasive, drawing from the principles of acupuncture, reflexology, and cellular physiology. These treatments aim to stimulate nerves to enhance the production of vital nerve chemicals, addressing the oxidative stress that often worsens Parkinson's symptoms.
The therapy has shown promising results, with patients around the world reporting improvements after daily sessions. But it doesn't stop there. Dr. Rhodes also discusses the broader benefits of VECTTOR treatments, such as improved circulation, better sleep due to white light exposure, and relief from neuropathy and allodynia. He emphasizes the importance of taking charge of one's health and the potential for personalized treatment plans tailored to individual needs.
Whether you're living with Parkinson's or supporting someone who is, this episode is packed with valuable information and hope. Tune in to learn more about this innovative therapy that's making waves in the Parkinson's community.